House Bill No. by Representative Brown amends R.S. 22:1657(B)(1) to enhance regulations surrounding pharmacy benefit managers (PBMs) in Louisiana. The bill introduces prohibitions against PBMs, insurers, or third-party administrators from altering health benefit plans based on information related to prescription drugs, specifically regarding financial or product assistance. This aims to ensure that patients receive comprehensive information about their prescription options, including cost and clinical efficacy, without restrictions imposed by their pharmacy benefit managers.

The bill also clarifies that pharmacy benefit managers cannot prevent pharmacies or pharmacists from informing patients about all relevant options for acquiring their medications, including the possibility of paying cash if it is more affordable than insurance copayments or deductibles. The proposed changes aim to promote transparency and patient choice in the prescription drug process, ultimately benefiting consumers by ensuring they are fully informed about their options.

Statutes affected:
HB509 Original: 22:1657(B)(1)